Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance: A Study to Determine if a Polygenic Risk Score Influences the Decision Making Options Amongst High Risk Women (GENRE 2)

NCT04474834 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04474834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04474834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance: A Study to Determine if a Polygenic Risk Score Influences the Decision Making Options Amongst High Risk Women (GENRE 2)
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Active, not recruiting
Start date
October 17, 2019
Completion date
December 15, 2029
Enrollment
737 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer